Sentences with phrase «biotechnology research group»

Not exact matches

Director Howy Jacobs and his research group at the Institute of Biotechnology are amongst many scientists worldwide who seek to answer the open questions, in their daily work.

She received her Ph.D. in biotechnology at KTH and initiated her research group at the Karolinska Institutet before moving to a tenure - track assistant professor position at the University of Houston, Texas.

The Biomolecular Nanotechnology Research Group at Bremen University focuses on environmental biotechnology.

I realize that your «Working Group On Review Of Bioengineering And Technology And Instrumentation Development Research», defined «bioengineering and technology» as encompassing areas such as biotechnology, functional genomics, informatics, chemistry and physics, nevertheless they did not discuss the problems experienced by physicists engaged in basic research on the frontier of physics and biology from the present system of study sResearch», defined «bioengineering and technology» as encompassing areas such as biotechnology, functional genomics, informatics, chemistry and physics, nevertheless they did not discuss the problems experienced by physicists engaged in basic research on the frontier of physics and biology from the present system of study sresearch on the frontier of physics and biology from the present system of study sections.

Professor Vicent Arbona belongs to the Department of Agricultural Sciences and the Natural World of the Universitat Jaume I and develops his research within the Ecophysiology and Biotechnology Investigation group, managed by professor Aurelio Gómez Cadenas.

Last January, days before a vote in the House of Representatives to loosen the rules on stem cell research, the journal Nature Biotechnology posted an article online, written by a group headed by Anthony Atala at Wake Forest University School of Medicine, reporting the discovery of stem cells isolated from amniotic fluid.

The model, built on more than three decades of research led by Vincent Chiang of the Forest Biotechnology Group at North Carolina State University, will speed the process of engineering trees for specific needs in timber, biofuel, pulp, paper and green chemistry applications.

Together with the VTT Technical Research Centre and the University of Turku, he founded and developed the Medical Biotechnology group in Turku, Finland between 2002 and 2008.

The two research groups who made the discovery, led by Senior Researcher, Docent Riikka Lund and Academy Professor Riitta Lahesmaa, work at the Turku Centre for Biotechnology.

The groups have agreed not to patent or use the data for research before making them public through the National Center for Biotechnology Information.

Its development is coordinated by Jim Procter and Geoff Barton in the Computational Biology group at the University of Dundee, School of Life Sciences with support from the Biotechnology and Biological Science Research Council and the Wellcome Trust.

The Department of Medical Biotechnology consists of many research groups covering biotechnology, vaccine development, infectious disease, immunopathology, microbiology, genetics and microbBiotechnology consists of many research groups covering biotechnology, vaccine development, infectious disease, immunopathology, microbiology, genetics and microbbiotechnology, vaccine development, infectious disease, immunopathology, microbiology, genetics and microbial immunity.

Its 680 members include companies, research institutions and universities, government groups and corporate service providers involved in biotechnology, pharmaceuticals, medical devices and diagnostics, medical informatics and related businesses.

Since 2007 he is heading the research group «Cellular Networks & Systems Biology» at the Biotechnology Center in Dresden, Germany focusing on computational systems biology and statistical genetics.

Subsequently, he founded and developed the Medical Biotechnology group at the University of Turku, together with the VTT Technical Research Centre, Finland.

As in the successful biotechnology companies and leading academic research groups, Trends in Biotechnology reflects the view that biotechnology is the integrated use of many biological technologies — from molecular genetics to biochemicalbiotechnology companies and leading academic research groups, Trends in Biotechnology reflects the view that biotechnology is the integrated use of many biological technologies — from molecular genetics to biochemicalBiotechnology reflects the view that biotechnology is the integrated use of many biological technologies — from molecular genetics to biochemicalbiotechnology is the integrated use of many biological technologies — from molecular genetics to biochemical engineering.

The Department of Medical Biotechnologies consists of many research groups covering biotechnology, vaccine development, infectious disease, immunopathology, microbiology, genetics and microbial immunity.

Dr. Harris started his career in biotechnology in 1981 as a group leader in Molecular Biology at Celltech Group and from 1989 to 1993 was Director of Biotechnology at Glaxo Group Research in the U.K.. From 1993 until 1999, Dr. Harris was Chief Scientific Officer and Vice President of Research and Development at Sequana Therapeutics Inc. in San Diego, which became Axys Pharmaceuticals, Inc. in 1998 and was subsequently acquired by Celbiotechnology in 1981 as a group leader in Molecular Biology at Celltech Group and from 1989 to 1993 was Director of Biotechnology at Glaxo Group Research in the U.K.. From 1993 until 1999, Dr. Harris was Chief Scientific Officer and Vice President of Research and Development at Sequana Therapeutics Inc. in San Diego, which became Axys Pharmaceuticals, Inc. in 1998 and was subsequently acquired by Celera Genogroup leader in Molecular Biology at Celltech Group and from 1989 to 1993 was Director of Biotechnology at Glaxo Group Research in the U.K.. From 1993 until 1999, Dr. Harris was Chief Scientific Officer and Vice President of Research and Development at Sequana Therapeutics Inc. in San Diego, which became Axys Pharmaceuticals, Inc. in 1998 and was subsequently acquired by Celera GenoGroup and from 1989 to 1993 was Director of Biotechnology at Glaxo Group Research in the U.K.. From 1993 until 1999, Dr. Harris was Chief Scientific Officer and Vice President of Research and Development at Sequana Therapeutics Inc. in San Diego, which became Axys Pharmaceuticals, Inc. in 1998 and was subsequently acquired by CelBiotechnology at Glaxo Group Research in the U.K.. From 1993 until 1999, Dr. Harris was Chief Scientific Officer and Vice President of Research and Development at Sequana Therapeutics Inc. in San Diego, which became Axys Pharmaceuticals, Inc. in 1998 and was subsequently acquired by Celera GenoGroup Research in the U.K.. From 1993 until 1999, Dr. Harris was Chief Scientific Officer and Vice President of Research and Development at Sequana Therapeutics Inc. in San Diego, which became Axys Pharmaceuticals, Inc. in 1998 and was subsequently acquired by Celera Genomics.

The main conclusion to be drawn from the efforts of more than 130 research projects, covering a period of more than 25 years of research, and involving more than 500 independent research groups, is that biotechnology, and in particular GMOs, are not per se more risky than... conventional plant breeding technologies.

Alliance for Climate Education The Altshuller Institute for TRIZ Studies American Geological Institute American Society of Heating, Refrigerating, and Air - Conditioning Engineers (ASHRAE) Apollo Alliance Arizona State University Appalachian State University PSM in Engineering Physics - Instrumentation and Automation Association of American Universities Association of Public and Land - grant Universities Babson College Babson College Energy and Environmental Club Baker College Berkeley Energy Resources Collaborative Binghamton University - State University of New York Bloomsburg University Boston University Energy Club Breakthrough Institute CSTEM Teacher and Student Support Services The California State University California State University - Bakersfield California State University - Channel Islands California State University - Chico California State University - East Bay California State University - Fresno California State University - Fresno PSM Programs in Biotechnology and Water Resources California State University - San Bernardino California State University - Stanislaus California State University - Stanislaus PSM Program in Genetic Counseling Center for Genomic Sciences - Allegheny - Singer Research Institute Clemson University Columbia University Cornell University Council of Graduate Schools Council on Undergraduate Research Duke University EAST Initiative emPOWER, Brown University Student Energy Group Energy Action Coalition Engineers Without Borders - USA Florida Atlantic University Florida State University Focus the Nation Georgia Institute of Technology Global Exchange Harvard College Environmental Action Committee IEEE - USA LearnOnLine, Inc..

«The main conclusion to be drawn from the efforts of more than 130 research projects, covering a period of more than 25 years of research, and involving more than 500 independent research groups, is that biotechnology, and in particular GMOs, are not per se more risky than e.g. conventional plant breeding technologies.»

Day Pitney's interdisciplinary Life Sciences and Healthcare practice group represents a broad spectrum of healthcare, pharmaceutical, biotechnology, medical device, research and technology - related entities.